Intermittent versus daily oral iron for treatment of iron deficiency anemia in childre
Phase 3
- Conditions
- Health Condition 1: D508- Other iron deficiency anemias
- Registration Number
- CTRI/2023/07/054666
- Lead Sponsor
- niversity College of Medical Sciences, Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mild or moderate anemia and an underlying iron deficiency.
Exclusion Criteria
1 Apparent non-nutritional etiology of anemia (eg presence of obvious bleeding, features of chronic hemolytic anemia in form of hemolytic facies or firm hepatosplenomegaly, systemic or hematological malignancies)
2 Known or suspected chronic systemic disease
3 Received or receiving iron preparation during last 2 weeks
4 Received blood/packed cell transfusion within last 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in proportion of anemia (Hb11g/dl) after 12 weeks of therapy between groupsTimepoint: Baseline and 12 weeks
- Secondary Outcome Measures
Name Time Method 1 Difference in proportion of non-responders at 4 weeks between groups <br/ ><br>2 Difference in rise in hemoglobin & MCV at 4,8,12 weeks between groups <br/ ><br>3 Difference in rise in serum ferritin at 12 weeks between groups <br/ ><br>4 Frequency of adverse effects, compliance & caregiver satisfaction (Likert scale) <br/ ><br>Timepoint: Baseline, 4, 8 & 12 weeks